AGREEMENT

EXHIBIT A

AGREEMENT

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Tarsus Pharmaceuticals, Inc.

Date: November 6, 2024				XXXXXXX LIFE SCIENCES IX, L.P.
				By FHMLS IX, L.P., its general partner
				By FHMLS IX, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: November 6, 2024				FHMLS IX, L.P.
				By FHMLS IX, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: November 6, 2024				FHMLS IX, L.L.C.
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: November 6, 2024				By:		*
						Xxxxx Xxxxxx
Date: November 6, 2024				By:		*
						Xxxxxxx Xxxxx
Date: November 6, 2024				*By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, as Attorney-in-Fact

* This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.